Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
Tremelimumab accepted under Priority Review in the US for patients with unresectable liver cancer in combination with Imfinzi
-
Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations
-
Enhertu granted Priority Review in the US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
-
Ultomiris demonstrated sustained improvements in functional activities and quality of life in adults with generalised myasthenia gravis through 60 weeks
-
AZD8233 reduced low-density lipoprotein cholesterol levels by 73% in patients with high-risk hypercholesterolemia in ETESIAN Phase IIb trial
-
Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
-
AstraZeneca aims to transform the oncology treatment landscape with diverse early pipeline and novel combinations at AACR
-
Evusheld long-acting antibody combination approved in the EU for pre-exposure prophylaxis (prevention) of COVID-19 in a broad population
-
Evusheld long-acting antibody combination recommended for approval in the EU for the pre-exposure prophylaxis (prevention) of COVID-19
-
Update on CALLA Phase III trial of concurrent use of Imfinzi and chemoradiotherapy in locally advanced cervical cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
